Angiotensin I-converting enzyme and metabolism of the haematological peptide N-acetyl-seryl-aspartyl-lysyl-proline

Clinical and Experimental Pharmacology & Physiology
M AziziJ Ménard

Abstract

1. Angiotensin I-converting enzyme (ACE) has two homologous active N- and C-terminal domains and displays activity towards a broad range of substrates. The tetrapeptide N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) has been shown to be hydrolysed in vitro by ACE and to be a preferential substrate for its N-terminal active site. This peptide reversibly prevents the recruitment of pluripotent haematopoietic stem cells and normal early progenitors into the S-phase. 2. Angiotensin I-converting enzyme inhibitors, given as a single dose to normal subjects or during long-term treatment in hypertensive patients, result in plasma AcSDKP levels five- to six-fold higher and urine concentrations 40-fold higher than those of control subjects and/or patients. Thus, AcSDKP is a natural peptide hydrolysed by the N-terminal domain of ACE in vivo. In addition, ACE may be implicated in the process of haematopoietic stem cell regulation by permanently degrading this natural circulating inhibitor of cell entry into the S-phase. 3. Besides hydrolysis by ACE, the second very effective mechanism by which AcSDKP is cleared from plasma is glomerular filtration. Because of its high sensitivity and specificity, the measurement of AcSDKP in plasma and uri...Continue Reading

References

Dec 1, 1990·International Journal of Radiation Oncology, Biology, Physics·W F WardJ M Hinz
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M LenfantE Frindel
Sep 1, 1994·Journal of Cardiovascular Pharmacology·E DelacrétazH R Brunner
Jan 1, 1994·Proceedings of the Society for Experimental Biology and Medicine·L NguyenA Molteni
Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·V DiveP Corvol

❮ Previous
Next ❯

Citations

Apr 19, 2005·The International Journal of Biochemistry & Cell Biology·Mazen KurdiGeorge W Booz
Apr 5, 2003·The International Journal of Biochemistry & Cell Biology·Ibrahim C Haznedaroglu, M Akif Oztürk
May 20, 2003·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Folker E FrankeSergi M Danilov
Dec 12, 2003·Nature Reviews. Drug Discovery·K Ravi AcharyaMario R W Ehlers
Oct 23, 2010·European Heart Journal·Massimo VolpeLuis M Ruilope
Jul 16, 2010·Heart Failure Clinics·Richard K Spence
Dec 17, 2011·Rapid Communications in Mass Spectrometry : RCM·Cédric MesminEric Ezan
Jul 24, 2010·The American Journal of Pathology·Ping LiSebastien Fuchs
Oct 7, 2004·International Review of Cytology·Nathalie MacoursRoger Huybrechts
Dec 25, 2007·Experimental Biology and Medicine·Arzu YarenMustafa Demirpence
Nov 17, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kashif HanifRituraj Konwar
Mar 20, 2018·Basic Research in Cardiology·Karin KohlstedtIngrid Fleming
Sep 7, 2019·Journal of Hypertension·Demetrios V VlahakosGiuseppe Mancia
Oct 23, 2018·World Journal of Cardiology·Vinasha RamasamyMpiko Ntsekhe
May 27, 2011·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Massimo VolpeUNKNOWN Executive Committee of the Italian Society of Hypertension
Apr 3, 2021·Molecular and Cellular Endocrinology·Elena Cantero-NavarroAlberto Ortiz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.